JC Chemical Co., Ltd. (KOSDAQ:137950)
South Korea · Delayed Price · Currency is KRW 3,315.00
0.00 (0.00%)
At close: Jan 30, 2026
JC Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 363,679 | 367,320 | 439,247 | 511,666 | 392,923 | 267,695 |
Other Revenue | 0 | - | - | -0 | -0 | - |
| 363,679 | 367,320 | 439,247 | 511,666 | 392,923 | 267,695 | |
Revenue Growth (YoY) | -4.43% | -16.38% | -14.15% | 30.22% | 46.78% | 32.28% |
Cost of Revenue | 331,615 | 337,011 | 387,798 | 452,689 | 339,599 | 236,203 |
Gross Profit | 32,064 | 30,309 | 51,449 | 58,977 | 53,324 | 31,493 |
Selling, General & Admin | 17,257 | 17,306 | 16,971 | 14,822 | 12,321 | 11,109 |
Amortization of Goodwill & Intangibles | 271.52 | 207.83 | 101.38 | 168.44 | 168.44 | 168.44 |
Other Operating Expenses | 132.21 | 54.8 | 29 | 36.16 | 19.57 | 18.61 |
Operating Expenses | 19,885 | 19,619 | 19,352 | 16,328 | 13,547 | 12,305 |
Operating Income | 12,179 | 10,690 | 32,097 | 42,649 | 39,777 | 19,188 |
Interest Expense | -9,046 | -8,342 | -5,481 | -4,886 | -3,353 | -3,778 |
Interest & Investment Income | 2,004 | 1,938 | 1,537 | 719.56 | 465.46 | 284.94 |
Earnings From Equity Investments | 186.67 | -174.86 | -80.76 | -138.74 | -70.5 | - |
Currency Exchange Gain (Loss) | -5,821 | 4,538 | 1,315 | -9,675 | 3,185 | -5,252 |
Other Non Operating Income (Expenses) | 971.02 | 928.19 | 775.27 | 904.71 | 834.41 | 792.66 |
EBT Excluding Unusual Items | 473.54 | 9,577 | 30,162 | 29,574 | 40,838 | 11,236 |
Gain (Loss) on Sale of Investments | 292.04 | -13.87 | -15.37 | -210.89 | -10.82 | 2.79 |
Gain (Loss) on Sale of Assets | -0.02 | -16.65 | -1.92 | -346.04 | 31.53 | 8.04 |
Asset Writedown | -68.33 | -104.27 | -34.44 | 1.08 | - | 127 |
Pretax Income | 697.24 | 9,442 | 30,111 | 29,018 | 40,859 | 11,373 |
Income Tax Expense | 1,593 | 3,795 | 8,986 | 9,831 | 7,487 | 3,988 |
Earnings From Continuing Operations | -896.04 | 5,647 | 21,125 | 19,187 | 33,372 | 7,385 |
Minority Interest in Earnings | 1,657 | 423.73 | -353.03 | 1,213 | -609.32 | 446.03 |
Net Income | 761.08 | 6,071 | 20,772 | 20,399 | 32,763 | 7,831 |
Net Income to Common | 761.08 | 6,071 | 20,772 | 20,399 | 32,763 | 7,831 |
Net Income Growth | -88.72% | -70.78% | 1.83% | -37.74% | 318.37% | -31.25% |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 |
Shares Change (YoY) | -1.44% | -0.73% | - | - | 0.11% | -0.10% |
EPS (Basic) | 35.26 | 278.44 | 945.81 | 928.82 | 1491.76 | 356.95 |
EPS (Diluted) | 34.81 | 278.00 | 945.81 | 928.82 | 1491.76 | 356.95 |
EPS Growth | -88.70% | -70.61% | 1.83% | -37.74% | 317.92% | -33.17% |
Free Cash Flow | -12,994 | -11,540 | 38,151 | 14,375 | -14,748 | -5,882 |
Free Cash Flow Per Share | -601.98 | -529.29 | 1737.09 | 654.54 | -671.52 | -268.09 |
Dividend Per Share | 150.000 | 150.000 | 150.000 | 160.000 | 150.000 | 90.000 |
Dividend Growth | - | - | -6.25% | 6.67% | 66.67% | 50.00% |
Gross Margin | 8.82% | 8.25% | 11.71% | 11.53% | 13.57% | 11.76% |
Operating Margin | 3.35% | 2.91% | 7.31% | 8.33% | 10.12% | 7.17% |
Profit Margin | 0.21% | 1.65% | 4.73% | 3.99% | 8.34% | 2.93% |
Free Cash Flow Margin | -3.57% | -3.14% | 8.69% | 2.81% | -3.75% | -2.20% |
EBITDA | 25,646 | 22,475 | 43,973 | 53,335 | 49,028 | 28,401 |
EBITDA Margin | 7.05% | 6.12% | 10.01% | 10.42% | 12.48% | 10.61% |
D&A For EBITDA | 13,468 | 11,786 | 11,876 | 10,686 | 9,251 | 9,214 |
EBIT | 12,179 | 10,690 | 32,097 | 42,649 | 39,777 | 19,188 |
EBIT Margin | 3.35% | 2.91% | 7.31% | 8.33% | 10.12% | 7.17% |
Effective Tax Rate | 228.51% | 40.19% | 29.84% | 33.88% | 18.32% | 35.07% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.